FIELD: medicine.
SUBSTANCE: invention refers to medicine, and concerns an agent for treating wound or burn skin lesions in the form of an external dosage form containing as an active substance hexapeptide tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine 0.02–0.5 wt%, pharmaceutically acceptable additive/pharmaceutically acceptable additives – the rest.
EFFECT: invention provides fast healing of wound and burn skin lesions by stimulating tissue regeneration processes in the affected area and reducing manifestations of productive inflammation.
3 cl, 5 ex, 4 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-VIRAL IMMUNOTROPIC AGENT FOR TREATMENT OF ARVI | 2018 |
|
RU2672888C1 |
| COSMETIC COMPOSITION WITH ANTI-AGING ACTIVITY TO PREVENT AGING AND CORRECT AGE-RELATED CHANGES IN SKIN, ITS USE (OPTIONS) | 2022 |
|
RU2806599C1 |
| HEXAPEPTIDE POSSESSING ANTIPANCREATONECROTIC ACTIVITY | 0 |
|
SU1348343A1 |
| AGENT FOR BURN DISEASE TREATMENT | 1993 |
|
RU2070054C1 |
| METHOD FOR IMMOBILISING BIOLOGICALLY ACTIVE SUBSTANCE (BAS) ON CARRIER (VERSIONS) AND BAS-CARRIER CONJUGATE PRODUCED BY SUCH METHODS | 2008 |
|
RU2409669C9 |
| METHOD FOR MODELLING OF RESPIRATORY BURST OF POLYMORPHONUCLEAR LEUKOCYTES | 0 |
|
SU1644206A1 |
| MEDICATION FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | 2020 |
|
RU2744125C1 |
| COMPOSITION BASED ON SYNTHETIC PEPTIDES AND LIPIDS FOR C HEPATITIS VACCINE | 2015 |
|
RU2675108C2 |
| OINTMENT FOR TREATING BURNS OF 1-3 DEGREE | 2019 |
|
RU2731175C1 |
| STABLE AQUEOUS PHARMACEUTICAL COMPOSITION FOR INHALATIONS CONTAINING A HEXAPEPTIDE | 2020 |
|
RU2739573C1 |
